(Q45142013)

10 December 2017

title

Neoadjuvant bevacizumab: surgical complications of mastectomy with and without reconstruction (English)

1 reference

10 December 2017

1 reference

8

Eric P Winer

1 reference

10 December 2017

3

Sara M Tolaney

1 reference

10 December 2017

10

Mehra Golshan

1 reference

10 December 2017

9

Ian E Krop

1 reference

10 December 2017

4

Steven J Isakoff

1 reference

10 December 2017

Kari Joanne Kansal

1

1 reference

10 December 2017

Laura Stewart Dominici

2

1 reference

10 December 2017

Barbara L Smith

5

1 reference

10 December 2017

Wei Jiang

6

1 reference

10 December 2017

Jane E Brock

7

1 reference

10 December 2017

language of work or name

English

0 references

publication date

13 September 2013

1 reference

Breast Cancer Research and Treatment

10 December 2017

published in

1 reference

10 December 2017

volume

141

1 reference

10 December 2017

issue

2

1 reference

10 December 2017

page(s)

255-259

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-013-2682-z

10 December 2017

exact match

0 references

cites work

Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2682-Z

Safety of bevacizumab in metastatic breast cancer patients undergoing surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2682-Z

Bevacizumab in combination with taxanes for the first-line treatment of metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2682-Z

Bevacizumab added to neoadjuvant chemotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2682-Z

Neoadjuvant chemotherapy and bevacizumab for HER2-negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2682-Z

Bevacizumab and central nervous system (CNS) hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2682-Z

A review on bevacizumab and surgical wound healing: an important warning to all surgeons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2682-Z

"Spontaneous," delayed colon and rectal anastomotic complications associated with bevacizumab therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2682-Z

Bevacizumab-associated fistula formation in postoperative colorectal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2682-Z

Thrombotic events in patients with cancer receiving antiangiogenesis agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2682-Z

Does neoadjuvant bevacizumab increase surgical complications in breast surgery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2682-Z

Impact of neoadjuvant chemotherapy on breast reconstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2682-Z

10.1007/S10549-013-2682-Z

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

10 December 2017

1003608302

0 references

1 reference